Deka Bank Deutsche Girozentrale Eli Lilly & CO Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Eli Lilly & CO stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 915,360 shares of LLY stock, worth $713 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

915,360

Previous 917,230 0.2%

Holding current value

$713 Million

Previous $839 Million 5.77%

% of portfolio

1.46%

Previous 1.51%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$772.14 - $960.02 $1.44 Million - $1.8 Million	-1,870 Reduced 0.2%	915,360 $790 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $4.42 Million - $5.55 Million	6,103 Added 0.67%	917,230 $839 Million
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $15.5 Million - $20.8 Million	26,229 Added 2.96%	911,127 $709 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $3.6 Million - $4.24 Million	-6,853 Reduced 0.77%	884,898 $515 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $56.1 Million - $77.4 Million	129,143 Added 16.93%	891,751 $486 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $3.79 Million - $5.07 Million	10,811 Added 1.44%	762,608 $358 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $9.47 Million - $11.1 Million	30,474 Added 4.22%	751,797 $255 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $22.4 Million - $26.1 Million	69,730 Added 10.7%	721,323 $263 Million
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $5.78 Million - $6.58 Million	19,486 Added 3.08%	651,593 $216 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $2.04 Million - $2.39 Million	7,306 Added 1.17%	632,107 $203 Million
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $11.1 Million - $13.8 Million	-47,481 Reduced 7.06%	624,801 $181 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $10.2 Million - $12.6 Million	45,147 Added 7.2%	672,282 $187 Million
Q3 2021 Oct 22, 2021	BUY	$221.6 - $272.71 $15.5 Million - $19.1 Million	70,078 Added 12.58%	627,135 $144 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $18.3 Million - $23.7 Million	-101,306 Reduced 15.39%	557,057 $128 Million
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $30 Million - $38.9 Million	-182,770 Reduced 21.73%	658,363 $122 Million
Q4 2020 Mar 12, 2021	BUY	$130.46 - $172.63 $31.4 Million - $41.6 Million	240,992 Added 40.16%	841,133 $140 Million
Q3 2020 Oct 29, 2020	BUY	$146.22 - $169.13 $43.8 Million - $50.7 Million	299,673 Added 99.74%	600,141 $86.8 Million
Q2 2020 Aug 04, 2020	BUY	$136.42 - $164.18 $255,241 - $307,180	1,871 Added 0.63%	300,468 $49.1 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $6.73 Million - $8.33 Million	-56,538 Reduced 15.92%	298,597 $41.6 Million
Q4 2019 Feb 04, 2020	SELL	$106.92 - $132.43 $28.2 Million - $34.9 Million	-263,844 Reduced 42.63%	355,135 $46.6 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $35.1 Million - $38.1 Million	-328,336 Reduced 34.66%	618,979 $69.8 Million
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $6.32 Million - $7.38 Million	57,088 Added 6.41%	947,315 $106 Million
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $14.5 Million - $17.1 Million	130,622 Added 17.2%	890,227 $94.3 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $13.8 Million - $15.5 Million	-130,622 Reduced 14.67%	759,605 $86.2 Million
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $5.99 Million - $7.48 Million	69,725 Added 8.5%	890,227 $0
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $180,620 - $207,295	-2,386 Reduced 0.29%	820,502 $70.4 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $11.9 Million - $14.1 Million	160,676 Added 24.26%	822,888 $63.7 Million
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $51 Million - $56.6 Million	662,212	662,212 $53.6 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Eli Lilly & CO Transaction History